logo

EHTH

eHealth·NASDAQ
--
--(--)
--
--(--)
8.27 / 10
Outperform

Fundamentally, eHealth rates Outperform with an 8.27 score. Strengths include high receivable turnover (40.66), fixed‑asset turnover (33.78), EPS YoY growth (71.4%), total profit growth (204%) and a solid current ratio (3.37). Weak points are low Profit‑MV and negative diluted ROE.

Fundamental(8.27)SentimentTechnical

Analysis Checks(8/10)

Net profit attributable to parent company shareholders / Net profit (%)
Value-25.98
Score2/3
Weight9.27%
1M Return2.40%
ROE (diluted) (YoY growth rate %)
Value-0.95
Score0/3
Weight-3.74%
1M Return-1.39%
Profit-MV
Value2.30
Score0/3
Weight-9.07%
1M Return-4.21%
Accounts receivable turnover ratio
Value40.66
Score3/3
Weight10.10%
1M Return2.73%
Basic earnings per share (YoY growth rate %)
Value71.43
Score3/3
Weight21.62%
1M Return5.24%
Total profit (YoY growth rate %)
Value204.09
Score3/3
Weight20.61%
1M Return5.00%
Fixed assets turnover ratio
Value33.78
Score3/3
Weight9.28%
1M Return2.53%
Diluted earnings per share (YoY growth rate %)
Value71.43
Score3/3
Weight21.84%
1M Return5.30%
Asset-MV
Value-0.55
Score2/3
Weight10.72%
1M Return2.56%
Current ratio
Value3.37
Score3/3
Weight9.37%
1M Return2.55%
Is EHTH undervalued or overvalued?
  • EHTH scores 8.27/10 on fundamentals and holds a Discounted valuation at present. Backed by its -1.10% ROE, 7.23% net margin, -3.76 P/E ratio, 0.04 P/B ratio, and 71.43% earnings growth, these metrics solidify its Outperform investment rating.